1-5 of 5
Authors: Annette Haberl
Save search
Sort by
Journal Article

Maraviroc Pharmacokinetics in HIV-1–Infected Pregnant Women Free

PDF
Angela Colbers and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1582–1589, https://doi.org/10.1093/cid/civ587
Published: 22 July 2015
Journal Article

Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients Get access

PDF
Christoph Stephan and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 10, October 2014, Pages 2809–2818, https://doi.org/10.1093/jac/dku213
Published: 23 June 2014
Journal Article

Immune Response after Two Doses of the Novel Split Virion, Adjuvanted Pandemic H1N1 Influenza A Vaccine in HIV-1–Infected Patients Get access

PDF
Markus Bickel and others
Clinical Infectious Diseases, Volume 52, Issue 1, 1 January 2011, Pages 122–127, https://doi.org/10.1093/cid/ciq003
Published: 01 January 2011
Journal Article

The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors Get access

PDF
Nils von Hentig and others
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 3, September 2008, Pages 579–582, https://doi.org/10.1093/jac/dkn204
Published: 13 May 2008
Journal Article

The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy Get access

PDF
Schlomo Staszewski and others
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 5, November 2006, Pages 1024–1030, https://doi.org/10.1093/jac/dkl375
Published: 06 September 2006